Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
471.6 GBX | +0.55% | +6.41% | -3.16% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
04-19 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Sales 2024 * | 1.84B 2.31B 3.16B | Sales 2025 * | 1.98B 2.49B 3.4B | Capitalization | 1.48B 1.86B 2.54B |
---|---|---|---|---|---|
Net income 2024 * | 64M 80.37M 110M | Net income 2025 * | 91M 114M 156M | EV / Sales 2024 * | 0.8 x |
Net cash position 2024 * | 8.12M 10.2M 13.93M | Net cash position 2025 * | 13.65M 17.14M 23.43M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
23
x | P/E ratio 2025 * |
15.7
x | Employees | 7,859 |
Yield 2024 * |
5.11% | Yield 2025 * |
6.07% | Free-Float | 94.58% |
Latest transcript on PageGroup plc
1 day | +0.55% | ||
1 week | +6.41% | ||
Current month | +5.69% | ||
1 month | -2.60% | ||
3 months | +4.47% | ||
6 months | +13.20% | ||
Current year | -3.16% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Kirk
CEO | Chief Executive Officer | - | 22-12-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Kaye Maguire
LAW | General Counsel | - | 18-09-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marie Metayer
BRD | Director/Board Member | 64 | 17-08-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Karen Geary
BRD | Director/Board Member | - | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 45 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 471.6 | +0.55% | 221,672 |
24-05-10 | 469 | +3.17% | 357,140 |
24-05-09 | 454.6 | +2.85% | 524,706 |
24-05-08 | 442 | -1.07% | 333,857 |
Delayed Quote London S.E., May 13, 2024 at 11:35 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.16% | 1.84B | |
-8.06% | 1.99B | |
+14.16% | 673M |
- Stock Market
- Equities
- MPI Stock